SciDev.Net
Science and Development Network
News, views and information about science, technology and the developing world
Search Archive
Features archive results 1-12 of 12 in Health and Drug development
New ideas in the war against tuberculosis
As tuberculosis strains that are resistant to all known drugs continue to emerge, scientists are trying new approaches to drug development.
The search for a polio-vanquishing vaccine
Polio is still with us, and scientists are having to rethink vaccination strategies for developing countries in the hope of eradication.
FEATURE | 12 February 2009 | EN
Global trials fall short on ethical standards
Developing countries are attractive places to run clinical trials, but in many places ethical oversight falls short.
East meets West in pharmaceutical drug deals
Big pharma drug companies are striking deals with Asian drug researchers to secure the future of the drug industry.
Vaccinating against 'Cantonese cancer'
Trials of a vaccine to prevent nasopharyngeal cancer will start soon in China, where it mainly affects the Cantonese-speaking population.
Therapeutic vaccines: a new hope for chronic diseases?
Vaccines for non-infectious illness could help developing nations tackle the growing burden of chronic disease. Maryke Steffens reports.
Chronic diseases: Facts and figures
Priya Shetty explores the truths and the myths about chronic diseases in the developing world.
Q&A: Advocating open source drugs
Leading geneticist Samir Brahmachari explains why India should kickstart a new open source approach to drug discovery for diseases like TB.
Turning plants into pills in Kenya
Traditional healers are joining forces with plant chemists in Kenya to develop antimalarials isolated from plants, reports Tatum Anderson.
FEATURE | 13 December 2007 | EN
China's malaria wars: the battle over monotherapy
The debate goes on over China's ongoing production of malaria monotherapy, which is thought to promote drug resistance. Jane Wu reports.
Shanghai surprise: China’s pharma breakthrough
By setting up a comprehensive R&D centre in China, Swiss drug giant Novartis breaks a longstanding trend. Richard Stone and Hao Xin report.
Chinese science: big ambition or big gamble?
An ambitious 15-year plan could make China a scientific heavyweight, or could prove too big to handle, report Hao Xin and Gong Yidong.
Information Services
Missed the Global Health Forum 2009?
Our blog, by SciDev.Net columnist Priya Shetty, will fill you in, as will our interview with the Global Forum's Gill Samuels
.jpg)
